A commonly used broad-spectrum antibiotic. A potent inhibitor of MMP-8 (neutrophil collagenase; IC50 = 30 µM) relative to MMP-1 (collagenase-1; IC50 = 300 µM). Also inhibits collagen synthesis by bovine articular chondrocytes cultured in alginate (IC50 = 25 µM). Inhibits nitric oxide synthesis by LPS-activated macrophages without affecting IL-10 release.
A commonly-used broad-spectrum antibiotic. A potent inhibitor of MMP-8 (neutrophil collagenase; IC50 = 30 µM) relative to MMP-1 (interstitial collagenase; IC50 = 300 µM). Also inhibits collagen synthesis by bovine articular chondrocytes cultured in alginate (IC50 = 25 µM). Inhibits nitric oxide synthesis by LPS-activated macrophages without affecting IL-10 release.
Biochem/physiol Actions
Cell permeable: no
Primary Target MMP-8
Product does not compete with ATP.
Reversible: no
Target IC50: 30 µM against MMP-8 (neutrophil collagenase); 25 µM inhibiting collagen synthesis by bovine articular chondrocytes cultured in alginate
Preparation Note
Follwing reconstitution, refrigerate (4°C). Stock solutions are stable for up to 5 days at 4°C.
Other Notes
D’Agostino, P., et al. 1998. J. Infect. Dis. 177, 489. Beekman, B., et al. 1997. Biochem. Biophys. Res. Commun. 237, 107. Hanemaaijer, R., et al. 1997. J. Biol. Chem. 272, 31504. Lauhio, A., et al. 1994. Clin. Exp. Immunol. Antimicrobiol. Agents Chemother. 36, 227. Sorsa, T., et al. 1994. Ann. N.Y. Acad. Sci.732, 112. Suomalainen, K., et al. 1992. Antimicrobiol. Agents Chemother.36, 227.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.